Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Solid Tumor 1 Osteoporosis 1 Lymphatic Metastasis 1 Lung Neoplasms 1

Interventions

Surgical Procedures, Operative 2 Radiotherapy 2 Lymph Node Excision 2 lncRNA LNMAT1, human 1 gewf solution 1 gadofosveset trisodium 1 fluoroazomycin arabinoside 1 Thyroidectomy 1 Technetium 1 Surgery, Computer-Assisted 1 Spectrum Analysis 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Methylene Blue 1 Metformin 1 Leuprolide 1 Indocyanine Green 1 Goserelin 1 Esophagectomy 1 Electroporation 1 Docetaxel 1 Cytoreduction Surgical Procedures 1 Congresses as Topic 1 Axitinib 1 Artificial Intelligence 1 Androgen Antagonists 1 Acceleration 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphatic Metastasis × Technetium × Clear all

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed

Lung Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡